Product Information
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB is a generic product labeled by Solco Healthcare US LLC, priced at $1.0778 per EA under NDC 43547046109. Its NADAC has been published 170 times since Jul 5, 2023.
FDA first approved this application on Apr 11, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB
candesartan cilexetil and hydrochlorothiazideStrength
32; 25 mg/1; mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547046109
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207455FDA Approved
4/11/2018
TE Code
AB
On Market Since
11/20/2017
Pharmacological Classes
Price Statistics
The NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB has been published 170 times since Jul 5, 2023, and over the history we have for it it has declined 17.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0778 per EA |
|---|---|
| All-time high | $1.7766 (Jan 10, 2024) |
| All-time low | $0.9491 (Oct 22, 2025) |
| 52-week high | $1.2433 |
| 52-week low | $0.9491 |
| Median price | $1.2101 |
| Average price | $1.2725 |
| Largest weekly change | +31.9% (Dec 20, 2023) |
| Weeks tracked | 170 |
| Tracking since | Jul 5, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Solco Healthcare US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
candesartan cilexetil and hydrochlorothiazide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB, manufactured by Solco Healthcare US LLC, is $1.0778 per EA (NDC 43547046109), effective Sep 30, 2026.
How has the price of CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB changed over time?
Over the history we have for it, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB has declined 17.9%. It has been tracked across 170 weekly CMS publications since Jul 5, 2023.
What are the highest and lowest recorded NADAC prices for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB?
Since Jul 5, 2023, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB has ranged from a low of $0.9491 (Oct 22, 2025) to a high of $1.7766 (Jan 10, 2024), with a median of $1.2101 per EA.
Are there cheaper alternatives to CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB, is $1.0214 per EA — about 5% below CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB.
Who manufactures CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB?
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB (NDC 43547046109) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.